This Cannabidiol market report covers market characteristics, size & growth, segmentation, regional & country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
The cannabidiol market size has grown exponentially in recent years. It will grow from $12.94 billion in 2024 to $17.85 billion in 2025 at a compound annual growth rate (CAGR) of 37.9%. The growth in the historic period can be attributed to changing regulatory environment, leading to increased legalization of cbd, growth in public awareness and acceptance of the potential health benefits of cbd, medical research supporting the use of cbd for various health conditions, emergence of diverse product categories, including cbd-infused foods, beverages, and skincare, and increased availability of cbd products through retail and e-commerce channels.
The cannabidiol market size is expected to see exponential growth in the next few years. It will grow to $58.98 billion in 2029 at a compound annual growth rate (CAGR) of 34.8%. The growth in the forecast period can be attributed to global legalization and regulatory harmonization of cbd products, pharmaceutical research and development for fda-approved cbd medications, increased consumer interest in cbd for mental health and relaxation, expansion ofThe pet cbd market and veterinary applications, and expansion ofThe hemp industry for cbd production. Major trends in the forecast period include development of novel cbd delivery methods and formulations, integration of blockchain and traceability solutions in the cbd supply chain, investment in r&d for new cbd-based pharmaceuticals, customized cbd formulations, and novel cbd delivery methods.
The growing market acceptance and utilization of CBD products, fueled by government approvals, are poised to drive the expansion of the cannabidiol market. CBD, derived from Cannabis Sativa, serves as a key ingredient in various consumer products and therapeutic applications. Recognizing the potential health benefits, governments worldwide are taking measures to improve regulatory pathways for the lawful marketing of CBD products, contributing to the market's growth. An illustrative example is the Therapeutic Goods Administration in Australia, which, in January 2022, approved approximately 210,000 SAS Category B applications for unapproved medicinal cannabis products.
The anticipated rise in neurological disorders is set to be a significant driver for the cannabidiol market. Neurological disorders affecting the central and peripheral nervous systems, including the brain and spinal cord, are increasingly prevalent. Cannabis has shown promise in treating neurological conditions by regulating calcium homeostasis and reducing neuroinflammation. As reported by the Parkinson's Foundation in December 2022, the incidence rate of Parkinson's disease in the United States surged to nearly 90,000 diagnoses annually, a notable increase from previous estimates of 60,000 yearly diagnoses.
Major companies in the cannabidiol market are concentrating on product innovation, particularly in developing non-psychotropic options that do not produce psychoactive effects. Non-psychotropic refers to substances that do not influence mental processes or alter consciousness, making them suitable for medicinal use without inducing a high. For example, in January 2024, Akumentis Healthcare Ltd., an India-based pharmaceutical manufacturing company, launched Clasepi for epilepsy treatment. This new DCGI-approved prescription cannabidiol was introduced in India to help manage seizures related to Lennox-Gastaut syndrome, Dravet syndrome, and Tuberous Sclerosis Complex in patients aged one year and older. This synthetic CBD product contains less than 0.1% THC, ensuring it is non-psychotropic. Clinical studies have shown its effectiveness in reducing seizures, especially when traditional antiseizure medications fail.
Major companies in the cannabidiol market are forming strategic partnerships to broaden their product offerings, enhance research and development capabilities, and strengthen their market presence. This approach allows them to provide essential communication services to individuals, businesses, and governments. Strategic partnerships involve companies leveraging each other's strengths and resources to achieve mutual benefits and success. For example, in February 2024, dsm-firmenich, a Netherlands-based chemical manufacturing company, teamed up with Zerion Pharma, a Denmark-based pharmaceutical firm. Through this collaboration, they aim to develop innovative solutions that combine DSM-Firmenich's expertise in advanced materials and formulations with Zerion Pharma's strengths in pharmaceutical development.
In December 2022, Prima, a US-based health and personal care products company, acquired Prospect Farms for an undisclosed amount. This acquisition is intended to enhance its product offerings and expand its market presence. This strategic move will incorporate Prospect Farms' expertise in high-quality hemp-derived products, reinforcing Prima's commitment to wellness and sustainability. Prospect Farms is a US-based health and wellness brand that specializes in hemp-derived products.
Major companies operating in the cannabidiol market include Endoca BV, Cannoid LLC, Medical Marijuana Inc., Folium Biosciences, Elixinol Global Limited, NuLeaf Naturals LLC, Isodiol International Inc., Pharmahemp d.o.o., Canopy Growth Corp., CV Sciences Inc., Medterra LLC, Cronos Group, CBD American Shaman LLC, Walgreens Boots Alliance, Aphria Inc., Maricann Inc., Tilray Inc., Organigram Holding Inc., CannTrust Holdings Company, Charlotte's Web Holdings Inc., Aurora Cannabis Inc., GW Pharmaceuticals PLC, Green Roads, HempMeds PX LLC, Eco Sciences, Bluebird Botanicals, HempFusion Inc., Kannaway LLC, Lazarus Naturals, Kazmira LLC, HempLife Today LLC.
Cannabidiol (CBD) is a chemical compound derived from the Cannabis Sativa plant, known as hemp or cannabis. It is utilized for various health conditions, including epilepsy, anxiety, dystonia, pain, Parkinson's disease, Crohn's disease, and more. Additionally, CBD is incorporated into coffee products, skincare items, and pet treats.
The primary product types of cannabidiol encompass oil, tinctures, suppositories, transdermal patches, vape oil, isolates, creams and roll-ons, capsules, tablets, and other formulations. CBD oil is formulated by extracting CBD from cannabis plants and blending it with a carrier oil like coconut or hemp seed oil. The sources of CBD include marijuana and hemp, utilized in oil and supplement production. Applications span medical, personal use, pharmaceuticals, and wellness, with distribution through channels like hospital pharmacies, retail pharmacies, online stores, and other distribution channels.
The cannabidiol market research report is one of a series of new reports that provides cannabidiol market statistics, including cannabidiol industry global market size, regional shares, competitors with a cannabidiol market share, detailed cannabidiol market segments, market trends and opportunities, and any further data you may need to thrive in the cannabidiol industry. This cannabidiol market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
North America was the largest region in the cannabidiol market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cannabidiol market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.
The countries covered in the cannabidiol market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA.
The cannabidiol market consists of sales of full spectrum CBD, broad spectrum CBD and CBD isolate forms of cannabidiol products. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The cannabidiol market size has grown exponentially in recent years. It will grow from $12.94 billion in 2024 to $17.85 billion in 2025 at a compound annual growth rate (CAGR) of 37.9%. The growth in the historic period can be attributed to changing regulatory environment, leading to increased legalization of cbd, growth in public awareness and acceptance of the potential health benefits of cbd, medical research supporting the use of cbd for various health conditions, emergence of diverse product categories, including cbd-infused foods, beverages, and skincare, and increased availability of cbd products through retail and e-commerce channels.
The cannabidiol market size is expected to see exponential growth in the next few years. It will grow to $58.98 billion in 2029 at a compound annual growth rate (CAGR) of 34.8%. The growth in the forecast period can be attributed to global legalization and regulatory harmonization of cbd products, pharmaceutical research and development for fda-approved cbd medications, increased consumer interest in cbd for mental health and relaxation, expansion ofThe pet cbd market and veterinary applications, and expansion ofThe hemp industry for cbd production. Major trends in the forecast period include development of novel cbd delivery methods and formulations, integration of blockchain and traceability solutions in the cbd supply chain, investment in r&d for new cbd-based pharmaceuticals, customized cbd formulations, and novel cbd delivery methods.
The growing market acceptance and utilization of CBD products, fueled by government approvals, are poised to drive the expansion of the cannabidiol market. CBD, derived from Cannabis Sativa, serves as a key ingredient in various consumer products and therapeutic applications. Recognizing the potential health benefits, governments worldwide are taking measures to improve regulatory pathways for the lawful marketing of CBD products, contributing to the market's growth. An illustrative example is the Therapeutic Goods Administration in Australia, which, in January 2022, approved approximately 210,000 SAS Category B applications for unapproved medicinal cannabis products.
The anticipated rise in neurological disorders is set to be a significant driver for the cannabidiol market. Neurological disorders affecting the central and peripheral nervous systems, including the brain and spinal cord, are increasingly prevalent. Cannabis has shown promise in treating neurological conditions by regulating calcium homeostasis and reducing neuroinflammation. As reported by the Parkinson's Foundation in December 2022, the incidence rate of Parkinson's disease in the United States surged to nearly 90,000 diagnoses annually, a notable increase from previous estimates of 60,000 yearly diagnoses.
Major companies in the cannabidiol market are concentrating on product innovation, particularly in developing non-psychotropic options that do not produce psychoactive effects. Non-psychotropic refers to substances that do not influence mental processes or alter consciousness, making them suitable for medicinal use without inducing a high. For example, in January 2024, Akumentis Healthcare Ltd., an India-based pharmaceutical manufacturing company, launched Clasepi for epilepsy treatment. This new DCGI-approved prescription cannabidiol was introduced in India to help manage seizures related to Lennox-Gastaut syndrome, Dravet syndrome, and Tuberous Sclerosis Complex in patients aged one year and older. This synthetic CBD product contains less than 0.1% THC, ensuring it is non-psychotropic. Clinical studies have shown its effectiveness in reducing seizures, especially when traditional antiseizure medications fail.
Major companies in the cannabidiol market are forming strategic partnerships to broaden their product offerings, enhance research and development capabilities, and strengthen their market presence. This approach allows them to provide essential communication services to individuals, businesses, and governments. Strategic partnerships involve companies leveraging each other's strengths and resources to achieve mutual benefits and success. For example, in February 2024, dsm-firmenich, a Netherlands-based chemical manufacturing company, teamed up with Zerion Pharma, a Denmark-based pharmaceutical firm. Through this collaboration, they aim to develop innovative solutions that combine DSM-Firmenich's expertise in advanced materials and formulations with Zerion Pharma's strengths in pharmaceutical development.
In December 2022, Prima, a US-based health and personal care products company, acquired Prospect Farms for an undisclosed amount. This acquisition is intended to enhance its product offerings and expand its market presence. This strategic move will incorporate Prospect Farms' expertise in high-quality hemp-derived products, reinforcing Prima's commitment to wellness and sustainability. Prospect Farms is a US-based health and wellness brand that specializes in hemp-derived products.
Major companies operating in the cannabidiol market include Endoca BV, Cannoid LLC, Medical Marijuana Inc., Folium Biosciences, Elixinol Global Limited, NuLeaf Naturals LLC, Isodiol International Inc., Pharmahemp d.o.o., Canopy Growth Corp., CV Sciences Inc., Medterra LLC, Cronos Group, CBD American Shaman LLC, Walgreens Boots Alliance, Aphria Inc., Maricann Inc., Tilray Inc., Organigram Holding Inc., CannTrust Holdings Company, Charlotte's Web Holdings Inc., Aurora Cannabis Inc., GW Pharmaceuticals PLC, Green Roads, HempMeds PX LLC, Eco Sciences, Bluebird Botanicals, HempFusion Inc., Kannaway LLC, Lazarus Naturals, Kazmira LLC, HempLife Today LLC.
Cannabidiol (CBD) is a chemical compound derived from the Cannabis Sativa plant, known as hemp or cannabis. It is utilized for various health conditions, including epilepsy, anxiety, dystonia, pain, Parkinson's disease, Crohn's disease, and more. Additionally, CBD is incorporated into coffee products, skincare items, and pet treats.
The primary product types of cannabidiol encompass oil, tinctures, suppositories, transdermal patches, vape oil, isolates, creams and roll-ons, capsules, tablets, and other formulations. CBD oil is formulated by extracting CBD from cannabis plants and blending it with a carrier oil like coconut or hemp seed oil. The sources of CBD include marijuana and hemp, utilized in oil and supplement production. Applications span medical, personal use, pharmaceuticals, and wellness, with distribution through channels like hospital pharmacies, retail pharmacies, online stores, and other distribution channels.
The cannabidiol market research report is one of a series of new reports that provides cannabidiol market statistics, including cannabidiol industry global market size, regional shares, competitors with a cannabidiol market share, detailed cannabidiol market segments, market trends and opportunities, and any further data you may need to thrive in the cannabidiol industry. This cannabidiol market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
North America was the largest region in the cannabidiol market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cannabidiol market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.
The countries covered in the cannabidiol market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA.
The cannabidiol market consists of sales of full spectrum CBD, broad spectrum CBD and CBD isolate forms of cannabidiol products. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Cannabidiol Market Characteristics3. Cannabidiol Market Trends and Strategies4. Cannabidiol Market - Macro Economic Scenario Including the Impact of Interest Rates, Inflation, Geopolitics and Covid and Recovery on the Market32. Global Cannabidiol Market Competitive Benchmarking and Dashboard33. Key Mergers and Acquisitions in the Cannabidiol Market34. Recent Developments in the Cannabidiol Market
5. Global Cannabidiol Growth Analysis and Strategic Analysis Framework
6. Cannabidiol Market Segmentation
7. Cannabidiol Market Regional and Country Analysis
8. Asia-Pacific Cannabidiol Market
9. China Cannabidiol Market
10. India Cannabidiol Market
11. Japan Cannabidiol Market
12. Australia Cannabidiol Market
13. Indonesia Cannabidiol Market
14. South Korea Cannabidiol Market
15. Western Europe Cannabidiol Market
16. UK Cannabidiol Market
17. Germany Cannabidiol Market
18. France Cannabidiol Market
19. Italy Cannabidiol Market
20. Spain Cannabidiol Market
21. Eastern Europe Cannabidiol Market
22. Russia Cannabidiol Market
23. North America Cannabidiol Market
24. USA Cannabidiol Market
25. Canada Cannabidiol Market
26. South America Cannabidiol Market
27. Brazil Cannabidiol Market
28. Middle East Cannabidiol Market
29. Africa Cannabidiol Market
30. Cannabidiol Market Competitive Landscape and Company Profiles
31. Cannabidiol Market Other Major and Innovative Companies
35. Cannabidiol Market High Potential Countries, Segments and Strategies
36. Appendix
Executive Summary
Cannabidiol Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on cannabidiol market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for cannabidiol? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cannabidiol market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) By Product: Oil; Tinctures; Suppository; Transdermal Patches; Vape Oil; Isolates; Creams and Roll-on; Capsules; Tablet; Other Products2) By Source: Marijuana; Hemp
3) By Treatment: CBD Oil; Supplements
4) By Application: Medical; Personal Use; Pharmaceuticals; Wellness
5) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Stores; Other Distribution Channels
Subsegments:
1) By Oil: Full-Spectrum CBD Oil; Broad-Spectrum CBD Oil; CBD Isolate Oil2) By Tinctures: CBD Tinctures with Flavoring; Unflavored CBD Tinctures
3) By Suppository: Rectal Suppositories; Vaginal Suppositories
4) By Transdermal Patches: CBD Patches for Pain Relief; CBD Patches for Sleep
5) By Vape Oil: CBD Vape Cartridges; CBD Vape Juice
6) By Isolates: CBD Powder; CBD Crystals
7) By Creams and Roll-on: Topical CBD Creams; CBD Roll-on Gels
8) By Capsules: Softgel Capsules; Hard Capsules
9) By Tablet: CBD Tablets; CBD Chewable Tablets
10) By Other Products: Gummies; Beverages; Edibles
Key Companies Mentioned: Endoca BV; Cannoid LLC; Medical Marijuana Inc.; Folium Biosciences; Elixinol Global Limited
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
The major companies featured in this Cannabidiol market report include:- Endoca BV
- Cannoid LLC
- Medical Marijuana Inc.
- Folium Biosciences
- Elixinol Global Limited
- NuLeaf Naturals LLC
- Isodiol International Inc.
- Pharmahemp d.o.o.
- Canopy Growth Corp.
- CV Sciences Inc.
- Medterra LLC
- Cronos Group
- CBD American Shaman LLC
- Walgreens Boots Alliance
- Aphria Inc.
- Maricann Inc.
- Tilray Inc.
- Organigram Holding Inc.
- CannTrust Holdings Company
- Charlotte's Web Holdings Inc.
- Aurora Cannabis Inc.
- GW Pharmaceuticals PLC
- Green Roads
- HempMeds PX LLC
- Eco Sciences
- Bluebird Botanicals
- HempFusion Inc.
- Kannaway LLC
- Lazarus Naturals
- Kazmira LLC
- HempLife Today LLC
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | January 2025 |
| Forecast Period | 2025 - 2029 |
| Estimated Market Value ( USD | $ 17.85 Billion |
| Forecasted Market Value ( USD | $ 58.98 Billion |
| Compound Annual Growth Rate | 34.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 32 |
